Skip to content
OpenCapital
Get started

Core Laboratories CLB Cash & Equivalents

Cash & Equivalents at other companies

Halliburton logo
HalliburtonHAL
$2B+11.0%
Schlumberger logo
Schlumberger SLB
$2.82B-4.0%
Baker Hughes logo
Baker HughesBKR
$14.76B+351%
Forum Energy Technologies logo
Forum Energy TechnologiesFET
$37.49M+20.4%
RPC logo
RPCRES
$200.73M-38.6%
Flowco Holdings Inc. logo
Flowco Holdings Inc.FLOC
$17.34M+2,424%

Other financials

Income statement

See full
Revenue$121.8M-1.4%
Operating income$1.9M-57.3%
Net income-$789.0K-412%
EPS (diluted)-$0.02—

Balance sheet

See full
Total debt$167.8M-6.8%
Total equity$268.9M+6.1%
Total assets$587.7M+0.3%

Cash flow

See full
Operating cash flow$4.0M-40.5%
CapEx$3.4M+23.8%
Free cash flow$517.0K-86.7%

Valuation

See full
Market cap$503.38M-13.5%
Enterprise value$648.4M-12.3%
P/E17.3×-3.4×
P/S1×-0.2×

Profitability

See full
Operating margin10.3%-0.2pp
Net margin5.5%+0.1pp
FCF margin4.3%-4.6pp

Returns & leverage

See full
Return on equity11.1%-0.4pp
Debt / equity0.6×-0.1×
Current ratio2×-0.2×

Where this comes from

Reported directly by Core Laboratories in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Core Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Laboratories's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Laboratories's cash & equivalents?
Core Laboratories (CLB) reported cash & equivalents of $22.82M in Q1 2026.
How has Core Laboratories's cash & equivalents changed year-over-year?
Core Laboratories's cash & equivalents increased by 3.2% year-over-year, from $22.11M to $22.82M.
What is the long-term trend for Core Laboratories's cash & equivalents?
Over 3 years (2022 to 2025), Core Laboratories's cash & equivalents has grown at a 13.7% compound annual growth rate (CAGR), from $15.43M to $22.7M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.